Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung BioLogics
Pharma
Astellas, Takeda, Chugai and more—Fierce Pharma Asia
Astellas CEO lays out the company's dealmaking plans. Takeda cuts jobs ahead of Trintellix patent expiry. Chugai seeks name recognition. And more.
Angus Liu
Jan 23, 2026 9:05am
Samsung Bio ekes ahead of Korea biopharma peers with great 2025
Jan 22, 2026 8:15am
China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia
Jan 9, 2026 3:00am
Samsung Bio shells out $280M to secure first US production site
Dec 22, 2025 9:14am
China deals, Daiichi-Merck ADC, Sun Pharma—Fierce Pharma Asia
Sep 11, 2025 8:50pm
Settlement allows Sandoz to launch Eylea biosimilar in late 2026
Sep 9, 2025 10:30am
